One molecule could usher revolutionary medicines for cancer, diabetes and genetic disease — but the US is turning its back on it

The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of uncertainty, scientists worry that revolutionary treatments for cancer, immune dysfunction and genetic disease may be left on the lab bench.